Carlsmed’s patient-specific spine implant, Aprevo, received a transitional pass-through payment from CMS.
This provides outpatient facilities with an incremental Medicare payment for procedures that use Aprevo, according to an Oct. 19 news release. The designation is part of CMS’ quarterly update of the 2021 Medicare Hospital Outpatient Prospective Payment System.
The nod comes weeks after CMS granted the new technology add-on payment. Both payment reimbursement programs went into effect Oct. 1.
Stryker CEO Kevin Lobo’s total compensation grew from $20.8 million in 2023 to just under $22 million in 2024, according…
Spinal cord stimulators have grown in popularity over the past several years as patients see benefits in the less-invasive procedure. …
Several spine and orthopedic companies have made progress with acquisitions in the first quarter of 2025. 1. Stryker has entered…
Comments are closed.